News & events

Importance of research management in the CPI presented at the Australasian Research Management Society Meeting (ARMS)

Dr Ed Bertram, Executive Officer was theme leader in the Health Stream at ARMS 2014. Ed spoke about the purpose of the CPI and bringing together of clinicians, scientists, geneticists, bioinformaticians and policy developers to work together. He also discussed the  need and use of NCRIS funded infrastructures such as the  NCI ANU supercomputer, Bio-platforms Australia genome sequencing and Australian Phenomics Network’s capabilities. The unique training and education programs and outreach to the community were discussed and Ed then gave the recent example of the discovery of a genetic cause of lupus from the centre.

Anselm Enders presents CPI at International Symposium in Korea

Anselm Enders, a chief investigator in the Centre for Personalised Immunology discussed the work and direction of the centre at an international meeting held in Yeosu, Korea.

The meeting gave an opportunity for Anselm and Executive Officer Ed Bertram to meet the Director of the new Jackson Laboratory of Genomic Medicine, Professor Charles Lee and discuss opportunities for future collaboration. This new facility has been built to lead the advance of translational genomics with the use of model organisms in the USA.  It will open in October and covers 189,000 square-feet of space and 300 scientists on the University of Connecticut health campus. At the meeting Professor Lee discussed the joint cancer genomics project between Seoul National University and his centre that has received $7.5M over 5 years from the South Korean government.


Genetic key to lupus shows potential of personalised medicine

Tuesday, August 19, 2014

Medical researchers have used DNA sequencing to identify a gene variant responsible for causing lupus in a young patient.

The development shows that for the first time, it is feasible for researchers to identify the individual causes of lupus in patients by using DNA sequencing, allowing doctors to target specific treatments to individual patients.

Lupus is a chronic autoimmune disease that affects one in 700 Australians, predominantly young and middle aged women.

Medical researchers at the Centre for Personalised Immunology, based at the John Curtin School of Medical Research (JCSMR), sequenced the genes of a young girl who suffered a stroke when she was four as a result of her lupus.

“We can now target her specific disease, and make treatments that will benefit her throughout her life,” said lead researcher Dr Julia Ellyard, (pictured), from the JCSMR.

>>ABC News